Study Evaluating the Nasopharyngeal Carriage in Healthy Children

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT00768833
First received: October 7, 2008
Last updated: April 11, 2014
Last verified: April 2014

October 7, 2008
April 11, 2014
October 2008
July 2014   (final data collection date for primary outcome measure)
Number and frequency of S. pneumonia positive serotypes [ Time Frame: 57 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00768833 on ClinicalTrials.gov Archive Site
Changes in number and frequency of S. pneumonia positive children at different ages over time [ Time Frame: 57 month ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Study Evaluating the Nasopharyngeal Carriage in Healthy Children
Nasopharyngeal Carriage in Children After Introduction of General Pneumococcal Immunization in Germany

The purpose of this study is to assess the prevalence of pneumococcal stereotypes in the nasopharynx of healthy children and to describe the changes of nasopharyngeal carriage at different ages over time.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

community sample

Healthy Subjects
Not Provided
1
healthy volunteer
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
240
July 2014
July 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

Main inclusion criteria:

  • Age at enrolment 3 to 4 month Main

Exclusion Criteria:

Exclusion criteria:

  • Malformation or injury of the nasopharynx
  • Known or suspected immunodeficiency
  • Relevant immunosuppression
  • Use of antibiotics up to 10 days prior to study inclusion
Both
3 Months to 4 Months
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00768833
0887X1-4453
No
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
April 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP